RYTM - Rhythm Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener
18 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-05-22 | RYTM | Orbimed Advisors LLC | See Remarks, 10% | S - Sale | $30.43 | -19,580 | 2,750,079 | -1% | -$595,768 | ||||||
| M | 2018-05-18 | RYTM | Orbimed Advisors LLC | 10% | S - Sale | $30.88 | -131,636 | 2,769,659 | -5% | -$4,065,440 | |||||
| D | 2017-10-10 | RYTM | Mpm Bioventures V, L.P. | 10% | P - Purchase | $17.00 | +100,000 | 2,696,392 | +4% | +$1,700,000 | |||||
| D | 2017-10-10 | RYTM | Foley Todd | Dir, 10% | P - Purchase | $17.00 | +100,000 | 2,696,392 | +4% | +$1,700,000 | |||||
| D | 2017-10-10 | RYTM | Viswanathan Ravi | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Sandell Scott D | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Mott David M | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Kerins Patrick J | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Baskett Forest | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Barris Peter J | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Barrett M James | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | New Enterprise Associates 13 LP | 10% | P - Purchase | $17.00 | +550,000 | 4,909,956 | +13% | +$9,350,000 | |||||
| D | 2017-10-10 | RYTM | Meeker David P | Dir | P - Purchase | $17.00 | +25,000 | 101,335 | +33% | +$425,000 | |||||
| D | 2017-10-10 | RYTM | Pfizer Inc | 10% | P - Purchase | $17.00 | +40,000 | 1,427,639 | +3% | +$680,000 | |||||
| D | 2017-10-10 | RYTM | Ipsen, S.A. | 10% | P - Purchase | $17.00 | +20,000 | 1,646,198 | +1% | +$340,000 | |||||
| D | 2017-10-10 | RYTM | Orbimed Advisors LLC | 10% | P - Purchase | $17.00 | +355,000 | 2,901,295 | +14% | +$6,035,000 | |||||
| D | 2017-10-10 | RYTM | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $17.00 | +355,000 | 937,010 | +61% | +$6,035,000 | |||||
| D | 2017-10-05 | RYTM | Baker Bros. Advisors LP | Former 10% owner | P - Purchase | $17.00 | +885,000 | 1,878,242 | +89% | +$15,045,000 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |